CLINICAL_TRIALS
trial_result
· 2008-02-25
Clinical Trial Update: Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder [Phase 2]
Summary
Phase 2 safety and efficacy study of AV608 in adults with social anxiety disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avera Pharmaceuticals | Conditions: Social Phobia | Phase 2 | Status: COMPLETED